Therapeutic effects of systemic or intramammary antimicrobial treatment of bovine subclinical mastitis during lactation
- 31 January 2008
- journal article
- research article
- Published by Elsevier BV in The Veterinary Journal
- Vol. 175 (1), 108-117
- https://doi.org/10.1016/j.tvjl.2006.12.005
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A Partial Budget Model to Estimate Economic Benefits of Lactational Treatment of Subclinical Staphylococcus aureus MastitisJournal of Dairy Science, 2005
- Factors Affecting Cure and Somatic Cell Count After Pirlimycin Treatment of Subclinical Mastitis in Lactating CowsJournal of Dairy Science, 2005
- Effective Treatment of Streptococcus uberis Clinical Mastitis to Minimize the Use of AntibioticsJournal of Dairy Science, 2002
- Determinants of Success or Failure in the Elimination of Major Mastitis Pathogens in Selective Dry Cow TherapyJournal of Dairy Science, 1999
- Factors Associated with Bacteriological Cure During Lactation After Therapy for Subclinical Mastitis Caused by Staphylococcus aureusJournal of Dairy Science, 1997
- Design of field trials for the evaluation of antibacterial products for therapy of bovine clinical mastitisJournal of Veterinary Pharmacology and Therapeutics, 1995
- Effectiveness of Intramammary Antibiotic Therapy Based on Somatic Cell CountJournal of Dairy Science, 1989
- Antibiotic Treatment of Mastitis: Comparison of Intramammary and Intramammary Plus Intramuscular TherapiesJournal of Dairy Science, 1988
- Mastitis Therapy for Cows with Elevated Somatic Cell Counts or Clinical MastitisJournal of Dairy Science, 1984
- Cost Benefit Analysis of Lactation Therapy with Somatic Cell Counts as Indications for TreatmentJournal of Dairy Science, 1983